Form 4: USANA CIO Sells All 4,553 Shares in Planned Transaction

USANA Health Sciences' Chief Information Officer, Peter Benedict, sold 4,553 shares of common stock for approximately $19.38 per share, reducing his direct beneficial ownership to zero.

Summary

• Peter Benedict, Chief Information Officer of USANA Health Sciences Inc. (USNA), sold 4,553 shares of common stock.
• The transaction occurred on March 3, 2026, at a weighted average price of $19.3848 per share, with prices ranging from $19.29 to $19.415.
• Following this sale, Mr. Benedict's direct beneficial ownership of USANA common stock is 0 shares.
• The transaction was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal due to the complete divestment of direct holdings by a key officer, despite the transaction being part of a pre-arranged 10b5-1 plan.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on immediate insider information.

Negatives

• An insider, specifically the Chief Information Officer, sold all of their directly beneficially owned shares (4,553 shares).
• The sale reduces the officer's direct equity alignment with the company's future performance to zero.

Risks

• The complete divestment of direct beneficial ownership by a key officer could be interpreted by the market as a lack of confidence, potentially impacting investor sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when executed under a 10b5-1 plan, are often scrutinized by investors for signals regarding management's long-term view of the company's prospects. While 10b5-1 plans mitigate concerns about opportunistic trading, a complete divestment of direct holdings by a CIO could still raise questions about future alignment.

Comparison to Industry Standards

• Insider sales are common across industries, particularly for executives managing personal finances or diversifying portfolios.
• The complete divestment of direct holdings by a C-suite executive, while not unprecedented, is less common than partial sales and can be viewed more critically than similar transactions at companies like Herbalife Nutrition (HLF) or Nu Skin Enterprises (NUS), which operate in similar direct-selling health and wellness sectors.
• The use of a 10b5-1 plan aligns with best practices for insider trading, similar to plans used by executives at major tech or consumer goods companies to avoid accusations of trading on material non-public information.

Related Party Transactions

• The sale of common stock by Peter Benedict, Chief Information Officer, is a related party transaction as he is an insider of USANA Health Sciences Inc.

Stakeholder Impact

• Shareholders: May interpret the complete sale of direct holdings by a CIO as a negative signal regarding future company performance or management's long-term commitment, potentially leading to decreased investor confidence.
• Employees: No direct impact mentioned, but could indirectly affect morale if perceived as a lack of confidence from leadership.

Key Dates

Recommendation

While the complete sale of direct holdings by a key officer is a notable event, the transaction was executed under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic trading. Given this context, and without additional information on the company's fundamentals or other market factors, a "hold" recommendation is appropriate as the signal is not strong enough for a "sell" but the complete divestment prevents a "buy" recommendation. Investors should monitor future insider activity and company performance.

Keywords

USANA Health Sciences, USNA, Insider Sale, Form 4, Peter Benedict, Chief Information Officer, Stock Transaction, 10b5-1 Plan